These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 4363652

  • 1. 5'-Nucleotide phosphodiesterase activity in rat hepatoma.
    Tsou KC, Morris HP, Lo KW, Muscato JJ.
    Cancer Res; 1974 Jun; 34(6):1295-8. PubMed ID: 4363652
    [No Abstract] [Full Text] [Related]

  • 2. Cyclic adenosine 3',5'-monophosphate phosphodiesterase activity in normal, differentiating, regenerating, and neoplastic liver.
    Clark JF, Morris HP, Weber G.
    Cancer Res; 1973 Feb; 33(2):356-61. PubMed ID: 4347469
    [No Abstract] [Full Text] [Related]

  • 3. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
    Rhoads AR, Morris HP, West WL.
    Cancer Res; 1972 Dec; 32(12):2651-5. PubMed ID: 4345399
    [No Abstract] [Full Text] [Related]

  • 4. Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).
    Hickie RA, Walker CM, Datta A.
    Cancer Res; 1975 Mar; 35(3):601-5. PubMed ID: 163686
    [Abstract] [Full Text] [Related]

  • 5. Modification of hexosaminidase isozymes in rat hepatoma.
    Weber A, Poenaru L, Lafarge C, Schapira F.
    Cancer Res; 1973 Aug; 33(8):1925-30. PubMed ID: 4352742
    [No Abstract] [Full Text] [Related]

  • 6. 5'-Nucleotide phosphodiesterase isoenzyme pattern in the serum of human hepatoma.
    Tsou KC, Ledis S, McCoy MG.
    Cancer Res; 1973 Oct; 33(10):2215-7. PubMed ID: 4355019
    [No Abstract] [Full Text] [Related]

  • 7. Isozymes of pyruvate kinase in liver and hepatomas of the rat.
    Farina FA, Shatton JB, Morris HP, Weinhouse S.
    Cancer Res; 1974 Jun; 34(6):1439-46. PubMed ID: 4363661
    [No Abstract] [Full Text] [Related]

  • 8. Dihydrouracil dehydrogenase activity in normal, differentiating and regnerating liver and in hepatomas.
    Queener SF, Morris HP, Weber G.
    Cancer Res; 1971 Jul; 31(7):1004-9. PubMed ID: 4397791
    [No Abstract] [Full Text] [Related]

  • 9. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine carbamyl transferase activity.
    Weber G, Queener SF, Morris HP.
    Cancer Res; 1972 Sep; 32(9):1933-40. PubMed ID: 4345042
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic AMP phosphodiesterase activity in three Morris hepatomas.
    Criss WE, Morris HP.
    Enzyme; 1975 Sep; 20(2):65-70. PubMed ID: 165075
    [Abstract] [Full Text] [Related]

  • 18. Enzymatic and immunological studies on pyruvate carboxylase in livers and liver tumors.
    Chang LO, Morris HP.
    Cancer Res; 1973 Sep; 33(9):2034-41. PubMed ID: 4353477
    [No Abstract] [Full Text] [Related]

  • 19. Dihydroorotate dehydrogenase in liver and Morris hepatomas.
    Sweeney MJ, Hoffman DH.
    Cancer Res; 1973 Feb; 33(2):394-6. PubMed ID: 4347471
    [No Abstract] [Full Text] [Related]

  • 20. Steroid delta 4 -reductase activity in hepatomas of differentgrowth rates.
    Houglum JE, Morris HP, Abul-Hajj YJ.
    Cancer Res; 1974 May; 34(5):938-41. PubMed ID: 4363065
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.